artemether / lumefantrine Oral Tablet [Coartem]
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Artemether/lumefantrine (Coartem®) has been used as a treatment for uncomplicated Plasmodium falciparum infection since 2004 in…
BackgroundSafety surveillance of widely used artemisinin-based combination therapy (ACT) is essential, but tolerability data in…
The interest in hot-melt extrusion as a drug delivery technology for the production of solid dispersion is growing rapidly…
BackgroundArtemether-lumefantrine (Coartem®; AL) is a standard of care for malaria treatment as an oral six-dose regimen, given…
Background: Ethiopia’s Health Extension Workers (HEW) deliver preventive interventions and treat childhood diarrhea and malaria…
Infants and children under five years of age are the most vulnerable to malaria with over 1,700 deaths per day from malaria in…
This article reviews the comprehensive data on the safety and tolerability from over 6,300 patients who have taken artemether…
BackgroundNumerous trials have demonstrated high efficacy and safety of artemisinin-based combination therapy (ACT) under…
BackgroundArtemether/lumefantrine (AL) has been adopted as the treatment of choice for uncomplicated malaria in Kenya and other…